Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Concurrent oncogene mutation profile in Chinese patients with stage Ib lung adenocarcinoma.

Medicine - 1 Dec 2014

Wen Ying-Sheng, Cai Ling, Zhang Xue-Wen, Zhu Jian-Fei, Zhang Zi-Chen, Shao Jian-Yong, Zhang Lan-Jun

Abstract excerpt

Molecular characteristics in lung cancer are associated with carcinogenesis, response to targeted therapies, and prognosis. With concurrent oncogene mutations being reported more often, the adjustment of treatment based on the driver gene mutations would improve therapy. We proposed to investigate the distribution of concurrent oncogene mutations in stage Ib lung adenocarcinoma in a Chinese population and find...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Class I Phosphatidylinositol 3-Kinases
Share to GTP Phosphohydrolases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mass Spectrometry

Share to Phosphatidylinositol 3-Kinases

Share to Proto-Oncogene Proteins c-akt

Share to Proto-Oncogene Proteins c-kit

Share to Proto-Oncogene Proteins c-met

Share to Receptor, ErbB-2

Source

Open in PubMed Open full text

Identifiers

PMID: 25546673
DOI: 10.1097/MD.0000000000000296
PMCID: PMC4602605

Genes

EGFR
KRAS
BRAF
ERBB2
KIT
NRAS
FGFR1
FGFR3
FLT3
HRAS
JAK2
MET
PDGFRA
RET

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Concurrent oncogene mutation profile in Chinese patients with stage Ib lung adenocarcinoma.PMID 25546673Read ↗

The co-mutation of EGFR and tumor-related genes leads to a worse prognosis and a higher level of tumor mutational burden in Chinese non-small cell lung cancer patientsSemantic proximity Read ↗

Concurrent gene alterations with EGFR mutation and treatment efficacy of EGFR-TKIs in Chinese patients with non-small cell lung cancer.Semantic proximity Read ↗

Driver gene alterations in NSCLC patients in southern China and their correlation with clinicopathologic characteristicsSemantic proximity Read ↗

Coexistence of EGFR with KRAS, or BRAF, or PIK3CA somatic mutations in lung cancer: a comprehensive mutation profiling from 5125 Chinese cohortsSemantic proximity Read ↗

Co-mutations of epidermal growth factor receptor and BRAF in Chinese non-small cell lung cancer patientsSemantic proximity Read ↗

Identification of five driver gene mutations in patients with treatment-naïve lung adenocarcinoma in Taiwan.Semantic proximity Read ↗

Prevalence of driver mutations in non-small-cell lung cancers in the People&rsquo;s Republic of ChinaSemantic proximity Read ↗

Genomic Profiling of Driver Gene Mutations in Chinese Patients With Non-Small Cell Lung CancerSemantic proximity Read ↗

Prevalence and Clinicopathological Characteristics of BRAF Mutations in Chinese Patients with Lung Adenocarcinoma.Semantic proximity Read ↗

Pathological Signature and Therapeutic Status of NSCLC Patients with Common or Rare Driver Gene Alterations in North China：A real world retrospective studySemantic proximity Read ↗

Comprehensive investigation of oncogenic driver mutations in Chinese non-small cell lung cancer patients.Semantic proximity Read ↗

Coexisting driver alterations in non-small cell lung cancer: Prevalence, clonal architecture, and impact on survival and progression.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.